RE: Takeover?26 Mar 2025 17:17
they are likely looking to buy companies at $1 billion to $2 billion with additional milestone payments tied to fda approvals and clinical data readouts, barclays' ****s said, rather than spend $14 billion on a company early in its commercial launch stage. hope so. must be right if barclays' ****s said so :)